-
1 Comment
Beijing Balance Medical Technology Co.,Ltd is currently in a long term uptrend where the price is trading 73.1% above its 200 day moving average.
From a valuation standpoint, the stock is 572.7% more expensive than other stocks from the None sector with a price to sales ratio of 83.5.
Based on the above factors, Beijing Balance Medical Technology Co.,Ltd gets an overall score of 1/5.
| ISIN | CNE100005X15 |
|---|---|
| Exchange | SHG |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Devices |
| PE Ratio | 54.53 |
|---|---|
| Target Price | None |
| Dividend Yield | 1.0% |
| Market Cap | 11B |
| Beta | 0.09 |
Beijing Balance Medical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of artificial bioprosthetic valve medical devices in China and internationally. It offers bovine pericardial, porcine aortic tissue, and limiting expandable artificial biological heart valves, as well as tricuspid annuloplasty ring for heart valve repair and treatment. The company also provides outflow tract single valve patch, pulmonary valved conduit, cardiothoracic biopatch, thoracic surgery biological patch, and dacron patch, as well as ventricular septal defect occluder, PDA occluder, ASD occluder, and cardiovascular occluder delivery system for congenital heart disease treatment. In addition, it offers neurosurgery microvascular pressure relief gasket, neurosurgical biopatch, and biological hernia patch for soft tissue repair. The company was founded in 2001 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688198.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
